Literature DB >> 17018551

Neuronal differentiation of transplanted embryonic stem cell-derived precursors in stroke lesions of adult rats.

Claudia Bühnemann1, Andreas Scholz, Christian Bernreuther, Christoph Y Malik, Holger Braun, Melitta Schachner, Klaus G Reymann, Marcel Dihné.   

Abstract

Stroke represents one of the leading causes of death and disability in Western countries, but despite intense research, only few options exist for the treatment of stroke-related infarction of brain tissue. In experimental stroke, cell therapy can partly reverse some behavioural deficits. However, the underlying mechanisms have remained unknown as most studies revealed only little, if any, evidence for neuronal replacement and the observed behavioural improvements appeared to be related rather to a graft-derived induction of a positive response in the remaining host tissue than to cell replacement by the graft itself. The present study was performed to test a murine embryonic stem cell (ESC)-based approach in rats subjected to endothelin-induced middle cerebral artery occlusion. Efficacy of cell therapy regarding graft survival, neuronal yield and diversity, and electrophysiological features of the grafted cells were tested after transplanting ESC-derived neural precursors into the infarct core and periphery of adult rats. Here, we show that grafted cells can survive, albeit not entirely, most probably as a consequence of an ongoing immune response, within the infarct core for up to 12 weeks after transplantation and that they differentiate with high yield into immunohistochemically mature glial cells and neurons of diverse neurotransmitter-subtypes. Most importantly, transplanted cells demonstrate characteristics of electrophysiologically functional neurons with voltage-gated sodium currents that enable these cells to fire action potentials. Additionally, during the first 7 weeks after transplantation we observed spontaneous excitatory post-synaptic currents in graft-derived cells indicating synaptic input. Thus, our observations show that ESC-based regenerative approaches may be successful in an acutely necrotic cellular environment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17018551     DOI: 10.1093/brain/awl261

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  76 in total

Review 1.  Stem cell therapy for cerebral ischemia: from basic science to clinical applications.

Authors:  Koji Abe; Toru Yamashita; Shunya Takizawa; Satoshi Kuroda; Hiroyuki Kinouchi; Nobutaka Kawahara
Journal:  J Cereb Blood Flow Metab       Date:  2012-01-18       Impact factor: 6.200

Review 2.  Stem cell-based models and therapies for neurodegenerative diseases.

Authors:  Shilpa Iyer; Khaled Alsayegh; Sheena Abraham; Raj R Rao
Journal:  Crit Rev Biomed Eng       Date:  2009

3.  Resveratrol promotes the survival and neuronal differentiation of hypoxia-conditioned neuronal progenitor cells in rats with cerebral ischemia.

Authors:  Yao Yao; Rui Zhou; Rui Bai; Jing Wang; Mengjiao Tu; Jingjing Shi; Xiao He; Jinyun Zhou; Liu Feng; Yuanxue Gao; Fahuan Song; Feng Lan; Xingguo Liu; Mei Tian; Hong Zhang
Journal:  Front Med       Date:  2020-12-01       Impact factor: 4.592

Review 4.  Special cells, special considerations: the challenges of bringing embryonic stem cells from the laboratory to the clinic.

Authors:  R C Addis; J W M Bulte; J D Gearhart
Journal:  Clin Pharmacol Ther       Date:  2008-03       Impact factor: 6.875

5.  Molecular and magnetic resonance imaging of human embryonic stem cell-derived neural stem cell grafts in ischemic rat brain.

Authors:  Marcel M Daadi; Zongjin Li; Ahmet Arac; Brad A Grueter; Marc Sofilos; Robert C Malenka; Joseph C Wu; Gary K Steinberg
Journal:  Mol Ther       Date:  2009-05-12       Impact factor: 11.454

6.  Human Neural Stem/Progenitor Cells Derived From Epileptic Human Brain in a Self-Assembling Peptide Nanoscaffold Improve Traumatic Brain Injury in Rats.

Authors:  Ali Jahanbazi Jahan-Abad; Sajad Sahab Negah; Hassan Hosseini Ravandi; Sedigheh Ghasemi; Maryam Borhani-Haghighi; Walter Stummer; Ali Gorji; Maryam Khaleghi Ghadiri
Journal:  Mol Neurobiol       Date:  2018-04-12       Impact factor: 5.590

7.  Neural stem cell-based therapy for ischemic stroke.

Authors:  Zaal Kokaia; Vladimer Darsalia
Journal:  Transl Stroke Res       Date:  2011-08-11       Impact factor: 6.829

Review 8.  Neural stem cell therapies and hypoxic-ischemic brain injury.

Authors:  Lei Huang; Lubo Zhang
Journal:  Prog Neurobiol       Date:  2018-05-21       Impact factor: 11.685

Review 9.  Stem cells in human neurodegenerative disorders--time for clinical translation?

Authors:  Olle Lindvall; Zaal Kokaia
Journal:  J Clin Invest       Date:  2010-01       Impact factor: 14.808

10.  The effect of an NgR1 antagonist on the neuroprotection of cortical axons after cortical infarction in rats.

Authors:  Hong Zhan; Shu-Jie Sun; Jie Cai; Ying-Qing Li; Chun-Lin Hu; Daniel H S Lee; Kwok-Fai So; Xin Li
Journal:  Neurochem Res       Date:  2013-03-24       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.